InvestorsHub Logo
Followers 1
Posts 108
Boards Moderated 0
Alias Born 03/11/2016

Re: None

Wednesday, 06/22/2016 10:17:12 AM

Wednesday, June 22, 2016 10:17:12 AM

Post# of 16885
June 20, 2016 report on forward P/E rations by sector http://www.yardeni.com/pub/mktbriefsppesecind.pdf - page 8.

Pharmaceuticals show 15.8 p/e on forward looking based on consensus estimate 12 mo projected earnings.

Using our *known* earnings of $15M approval milestone, divided by 20.06M shares = $0.7477/sh, and not adding any other revenue or potential revenue, milestones or royalties, we should be sitting at $11.81/sh. If you use the "consensus estimates" of $.54/sh, we should be at $8.53.

I am at a loss for why the stock is behaving like it is, but I will continue to buy when I can. I fully believe in this stock.

Good news around the corner:

1) admission into the Russel microcap index (reconstitution should be finalized after close this Friday);

2) ROW updates and (please let it be) partnership announcements soon

3) milestone earnings announcement leading to actual earnings to announce in August's ER

4) royalty payments leading to more actual earning to announce in November's ER

5) continued good news from Braeburn and Titan regarding number of doctors training and patients treated
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News